Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 626,821 | 514,642 | 219,993 | 977,062 | 671,066 |
| Depreciation Amortization | 260,089 | 169,961 | 82,510 | 427,961 | 334,761 |
| Income taxes - deferred | -61,244 | -30,317 | 8,042 | -137,351 | -72,580 |
| Accounts receivable | -72,719 | -22,955 | -20,201 | -100,442 | -96,215 |
| Other Working Capital | -47,731 | -37,101 | -77,650 | -351,482 | -247,648 |
| Other Operating Activity | 488,401 | 171,146 | 124,201 | 259,150 | 206,174 |
| Operating Cash Flow | $1,193,617 | $765,376 | $336,895 | $1,074,898 | $795,558 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 29,991 | 29,991 |
| PPE Investments | -124,220 | -85,260 | -38,209 | -165,646 | -110,129 |
| Net Acquisitions | -124,928 | -39,976 | -39,976 | N/A | N/A |
| Purchase Of Investment | -1,377,268 | -943,606 | -701,385 | -3,592,205 | -3,037,675 |
| Sale Of Investment | 2,490,363 | 2,002,543 | 1,029,307 | 3,332,829 | 2,340,160 |
| Investing Cash Flow | $863,947 | $933,701 | $249,737 | $-395,031 | $-777,653 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,586 | 2,912 | -1,826 | 12,275 | -22,494 |
| Debt Repayment | -16,182 | -14,142 | -2,011 | -10,867 | -10,867 |
| Common Stock Issued | 80,447 | 63,193 | 52,818 | 47,810 | 33,236 |
| Common Stock Repurchased | -2,077,579 | -1,609,334 | -577,580 | -751,170 | -57,631 |
| Other Financing Activity | -117 | 7,785 | 5,139 | -22,199 | 362 |
| Financing Cash Flow | $-2,010,845 | $-1,549,586 | $-523,460 | $-724,151 | $-57,394 |
| Exchange Rate Effect | -1,851 | -10,418 | -5,502 | 3,788 | 2,892 |
| Beginning Cash Position | 581,889 | 581,889 | 581,889 | 622,385 | 622,385 |
| End Cash Position | 626,757 | 720,962 | 639,559 | 581,889 | 585,788 |
| Net Cash Flow | $44,868 | $139,073 | $57,670 | $-40,496 | $-36,597 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,193,617 | 765,376 | 336,895 | 1,074,898 | 795,558 |
| Capital Expenditure | -124,220 | -85,260 | -38,209 | -165,646 | -110,129 |
| Free Cash Flow | 1,069,397 | 680,116 | 298,686 | 909,252 | 685,429 |